Rhabdomyolysis after Concomitant Use of Cyclosporine, Simvastatin, Gemfibrozil, and Itraconazole

Abstract

Clinicians must be aware of drugs metabolized via cytochrome P450 isoenzymes and identify those requiring risk-versus-benefit analysis before prescribing. Patients need to be educated as to signs and symptoms requiring immediate physician intervention.